Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Strategic Asset Allocation Index
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Strategic Asset Allocation Index of 37.5% as of June 2023. Strategic assets (PP&E of TL322.80 Million plus long-term investments of TL-) total TL322.80 Million, measured against net assets of TL861.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Strategic Asset Allocation Index (2020–2022)
This chart shows how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 37.5%, representing strategic assets of TL322.80 Million against net assets of TL861.86 Million TRY. Explore cash efficiency ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Meditera Tibbi Malzeme Sanayi ve Ticaret stock valuation.
| Year | SAAI | Strategic Assets (TRY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 34.0% | TL301.67 Million | TL301.67 Million | TL- | TL887.08 Million | ▲ +19.0 pp |
| 2021 | 15.0% | TL85.24 Million | TL85.24 Million | TL- | TL569.37 Million | ▼ -26.2 pp |
| 2020 | 41.2% | TL89.49 Million | TL89.49 Million | TL- | TL217.15 Million | — |